Carisbamate (RWJ-333369) is an orally active neuromodulator that prevents the development and generation of epileptiform discharges and exhibits neuroprotective effects following in vitro epileptiform injury; it demonstrates potent antiepileptic activity in genetic models of generalized convulsive and non-convulsive seizures.